CLA (Conjugated Linoleic Acid)
Supplements · Fatty Acids · Supplement, Typed Supps
A modified fat sold as a fat burner — the real effect is tiny.
Stage by stage
- Intake (Softgel): Digested like other dietary fats.
- Small intestine (Standard fat absorption): Absorbed alongside dietary fat.
- Bloodstream (Incorporated into tissue): Carried through the blood to fat and muscle tissue.
- Body composition (Modest, inconsistent effect): Studied for effects on body fat percentage, with results that are small and inconsistent across trials.
What the evidence supports
- Reducing body fat — limited evidence. Meta-analyses find a statistically significant but very small reduction in fat mass (on the order of a few hundred grams), widely judged to be below clinical importance.
- Producing meaningful weight loss in real-world use — insufficient evidence. Despite heavy marketing, pooled effects on body weight are trivial and inconsistent, so it does not deliver the fat loss it is sold for.
- Evidence that it causes Worsening blood-sugar control and liver enzymes — limited evidence. A pooled analysis found CLA raised fasting glucose and one liver enzyme (AST); animal data show fatty liver and insulin resistance at high doses. The signal is a reason for caution rather than proof of harm.
Typical dose
Around 3–3.4 g/day in trials
Upper limit: No established UL; higher doses raise the metabolic-safety concerns above
Timing
With food, standard dosing.
Time to effect
- Months: Any reported body composition change in studies, where present at all.
Medication interactions
- Diabetes medication (metformin, insulin, sulfonylureas): Not a pharmacokinetic interaction. A pooled analysis of trials found CLA raised fasting glucose, which pulls against what the medication is doing. If you take it alongside diabetes treatment, monitoring is sensible — and it is fair to ask what you are getting in return for that, given how small the fat-loss effect is. (moderate)
- Medicines requiring liver-enzyme monitoring (statins, methotrexate, isotretinoin): The same pooled analysis found CLA raised AST, and animal work shows fatty liver at high doses. It can muddy the interpretation of routine liver-function monitoring, so tell whoever orders the test that you take it. (moderate)
Common myth
“CLA is a proven fat burner.” In reality: Meta-analyses generally show only a very small effect on body fat, well short of its marketing reputation.
Food sources
More in Fatty Acids
In the glossary
Sources